Research Outputs (103)

Sort by: Date | Title

10 | 25 | 50 | 100

1/11

4 A B C D E F G H I L M N O P Q R S T U V W Z All

4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A(2) and its receptor
Huang RY, Li MY, Hsin MKY, Underwood MJ, Ma LT, Mok TSK, Warner TD, Chen GG ( 2011 )
ONCOGENE
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1038/onc.2010.390
A Comparative Clinical and Cost-effectiveness Evaluation of Gefitinib and Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
LOPES Dl Gilberto, SEGEL Joel, TAN Daniel, DO Young, MOK Shu Kam Tony, FINKELSTEIN Eric ( 2011 )
Proceedings of the 14th World Conference on Lung Cancer
Invited conference paper presented and published in conference proceedings
ADAMTS8 at 11q25 is a tumor suppressor antagonizing Ras-signaling and methylated in multiple carcinomas
TAO Qian, CHOI Ching Gee, WANG Yajun ( 2011 )
102nd AACR Annual Meeting
Invited conference paper presented and published in conference proceedings
A novel 16q23 tumor suppressor gene, TUSC8, induces tumor cell apoptosis and is epigenetically silenced in nasopharyngeal carcinoma
YING JIANMING, TAN J, LI Lili, TAO Qian ( 2011 )
The 5th International Symposium on Nasopharyngeal Carcinoma
Invited conference paper presented and published in conference proceedings
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors
Low JSW, Tao Q, Ng KM, Goh HK, Shu XS, Woo WL, Ambinder RF, Srivastava G, Shamay M, Chan ATC, Popescu NC, Hsieh WS ( 2011 )
ONCOGENE
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1038/onc.2010.576
Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients
Chan V.T.C., Yeo W. ( 2011 )
Breast Cancer: Targets and Therapy
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.2147/BCTT.S12955
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells
Lui VWY, Lau CPY, Ho K, Ng MHL, Cheng SH, Tsao SW, Tsang CM, Lei KIK, Chan ATC, Mok TSK ( 2011 )
INVESTIGATIONAL NEW DRUGS
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1007/s10637-010-9470-y
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
Blumenschein GR, Kabbinavar F, Menon H, Mok TSK, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L ( 2011 )
ANNALS OF ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdq731
A Phase II Study of Epigenetic Therapy Using Belinostat for Patients With Unresectable Hepatocellular Carcinoma - a Multicenter Study of the Mayo Phase 2 Consortium (P2C) and the Cancer Therapeutics Research Group (CTRG)
YEO Winnie, CHUNG H C, CHAN Lam Stephen, WANG L Z, LIM R, PICUS J, BOYER M, ERLICHMAN C, CHAN Anthony Tak Cheung, GOH B C ( 2011 )
The European Multidisciplinary Cancer Congress
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S0959-8049(11)71908-6
A phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens
Hui EP, Taylor GS, Ma B, Chan SL, Ho R, Wong W, Jia H, Edwards C, Rickinson AB, Chan ATC, Steven NM ( 2011 )
Proc ASCO 2011
Invited conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/jco.2011.29.15_suppl.2592

10 | 25 | 50 | 100

1/11

Research Outputs (103)

Share Link

Our policy towards the use of cookies